丹参穴位注射对股骨头缺血性坏死患者髋关节功能的影响

目的:观察丹参穴位注射治疗股骨头缺血性坏死的疗效。方法:将股骨头缺血性坏死病人62髋随机分为髓芯减压组30髋和丹参穴注组32髋。注射用丹参(冻干,400 mg)用5 ml生理盐水溶解,于丹参穴注组患者股骨头缺血性坏死侧的环跳穴、居髎穴注射,每穴注射2.5 ml,每周3次,连续治疗6个月。依据成人股骨头缺血性坏死疗效评价法在首次治疗后1、3、6个月时分别对两组进行评分比较。结果:两种治疗方法均可以明显减轻股骨头缺血性坏死患者的疼痛症状(P<0.01),但丹参穴注明显优于髓芯减压(P<0.01)。在髋关节活动度、生活能力、行走距离的改善上,髓芯减压组治疗前后比较无明显改善(P>0.05),丹参穴注组在治疗1、3、6个月时均有明显改善(P<0.01);丹参穴注明显优于髓芯减压(P<0.01)。结论:丹参穴位注射可以明显改善股骨头缺血性坏死患者的髋关节功能和生活能力。

Effect of Point Injection of Red-sage-root on the Hip Joint Function in Ischemic Femoral Head Necrosis Patients

Objective To observe the therapeutic effect of point injection of Danshen (Red-sage-root) for treating ischemic necrosis of femoral head in patients. Methods A total of 62 hips of ischemic femoral head necrosis were randomly divided into point-injection group (32 hips) and core decompression (CDC) group (30 hips) according to the random digits table method. Red-sage-root (freeze-dried) solved in 5 ml normal saline solution was injected into Huantiao (GB 30) and Juliao(GB 29) on the affected side, 2. 5 ml for each point, 3 times a week, for 6 consecutive months. Patients of CDC group were treated by core decompression surgery. The therapeutic effect was evaluated by the "Evaluating Method for Adult Avascular Necrosis of Femoral Head" (issued in Dandong in 1995). Results Compared with pre-treatment, scores of pain severity of two groups from the 1st month to the 6th month, joint-motion range, daily life activity and walking distance scores of point-injection group from the 1st month to the 6th month increased significantly (P<0. 01, P<0. 05); while those of joint-motion range, daily life activity and walking distance in CDC group had no apparent improvement (P>0. 05). The difference values between post-and pre-treatment in the scores of pain severity, joint-motion range, daily life activity and walking distance in point-injection group were all significantly higher than those in CDC group (P<0. 01). Conclusion Point-injection of red-sage-root can effectively relieve the pain severity, improve the hip joint-motion function and daily life activity in ischemic femoral head necrosis patients.